Monserum

Monserum LLC is a Mongolian biotechnology and pharmaceutical company based in Ulaanbaatar that specializes in the development of oral immunotherapies. The company is best known for its collaboration with Immunitor in developing hepcortespenlisimut-L (Hepko-V5), an oral therapeutic vaccine derived from heat-inactivated hepatitis antigens. Hepko-V5 has received Orphan Drug Designation from the US FDA for the treatment of hepatocellular carcinoma (HCC) and is currently in Phase 3 clinical trials. Monserum also manufactures and distributes other products, including the V5 immunomodulator for chronic hepatitis and Melagenin oil for vitiligo. The company's core technology involves the use of hydrolyzed pooled blood from virus carriers to create stable, orally administered treatments. Monserum plays a significant role in the Mongolian healthcare sector, particularly in addressing the high prevalence of liver disease and cancer in the region.